Effective Monday, December 6th,
the following MRD Flow panels have been updated with additional antibodies for
enhanced MRD detection. These panels are now run with 12-color flow cytometry
technique in one single tube for speed, efficiency, and thoroughness.
MRD Flow Panel – Markers will include: CD66c/CD123,
CD304/CD73, 7AAD, CD34, CD13/CD33, CD10, CD19, CD20, CD45, CD38, CD58,
Updated Flow User's Guide is now available for download on NeoLINK under Documentation.
- Myeloma (MM) MRD Flow Panel – Markers will include: VS38c,
CD269 (BCMA), CD117, CD56, cKappa, CD27, cLambda, CD138, CD45, CD20, CD81,
Lung Tumor Profile
Please note a date change to Monday, December 13th
Detection of ALK, RET, and ROS1
mutations (SNVs and indels) will be added to the NeoTYPE®
Lung Tumor Profile beginning with samples received Monday, December 13th.
Understanding mutation status of these genes is important for therapeutic
management of patients with non-small cell lung cancer.
- No changes to level of service, CPT Codes,